Literature DB >> 16750350

Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's disease.

Eduardo M Torres1, Stephen B Dunnett.   

Abstract

In the unilateral rat model of Parkinson's disease (PD), amphetamine induced rotation is widely used as an index of both lesion deficits and of graft-derived recovery. We have analysed the time course of the rotational response in lesioned rats, and in rats with lesions and dopamine grafts. In lesioned rats, the rotation exhibited a typical dose-dependent response, with low rates of rotation in the first 10 min after injection, rising gradually to a maximum after 20-30 min. Grafted rats exhibited a peak of rotation in the first 10 min after injection, which then fell to a minimum after 30 min. We demonstrate that the response seen in grafted rats is both drug and dose-dependent and show that the rotational profile results from interaction of the grafted and intact striata which exhibit differential temporal responses to the amphetamine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750350     DOI: 10.1016/j.euroneuro.2006.04.009

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

1.  Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.

Authors:  Gwendalyn D King; Kurt M Kroeger; Catherine J Bresee; Marianela Candolfi; Chunyan Liu; Charlene M Manalo; A K M Ghulam Muhammad; Robert N Pechnick; Pedro R Lowenstein; Maria G Castro
Journal:  Mol Ther       Date:  2008-02-19       Impact factor: 11.454

Review 2.  Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.

Authors:  Marianela Candolfi; Kurt M Kroeger; A K M G Muhammad; Kader Yagiz; Catherine Farrokhi; Robert N Pechnick; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

Review 3.  The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson's Disease.

Authors:  Anders Björklund; Stephen B Dunnett
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

4.  A comparison of AAV-vector production methods for gene therapy and preclinical assessment.

Authors:  Marcus Davidsson; Matilde Negrini; Swantje Hauser; Alexander Svanbergsson; Marcus Lockowandt; Giuseppe Tomasello; Fredric P Manfredsson; Andreas Heuer
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

5.  Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism.

Authors:  Christopher R Apostol; Kelsey Bernard; Parthasaradhireddy Tanguturi; Gabriella Molnar; Mitchell J Bartlett; Lajos Szabò; Chenxi Liu; J Bryce Ortiz; Maha Saber; Katherine R Giordano; Tabitha R F Green; James Melvin; Helena W Morrison; Lalitha Madhavan; Rachel K Rowe; John M Streicher; Michael L Heien; Torsten Falk; Robin Polt
Journal:  Front Drug Discov (Lausanne)       Date:  2022-01-14

6.  Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.

Authors:  Matilde Negrini; Giuseppe Tomasello; Marcus Davidsson; Alexis Fenyi; Cécile Adant; Swantje Hauser; Elena Espa; Francesco Gubinelli; Fredric P Manfredsson; Ronald Melki; Andreas Heuer
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

7.  DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.

Authors:  Puneet K Sharma; Lisa Wells; Gaia Rizzo; Joanna L Elson; Jan Passchier; Eugenii A Rabiner; Roger N Gunn; David T Dexter; Ilse S Pienaar
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.